International Journal of Celiac Disease
ISSN (Print): 2334-3427 ISSN (Online): 2334-3486 Website: http://www.sciepub.com/journal/ijcd Editor-in-chief: Samasca Gabriel
Open Access
Journal Browser
Go
International Journal of Celiac Disease. 2020, 8(2), 50-53
DOI: 10.12691/ijcd-8-2-2
Open AccessCase Report

Risks of Lymphoma and Digestive Cancers in Patients with Celiac Disease: Cohort Study

A M. Mahmoudi1, , I. Benelbarhdadi1, C. Berhili1, N. Lagdali1, M. Borahma1 and FZ. Ajana1

1Department of Hepato-gastroenterology of medicine C University Hospital Ibn Sina, University Mohamed V, Rabat, Morocco

Pub. Date: June 25, 2020

Cite this paper:
A M. Mahmoudi, I. Benelbarhdadi, C. Berhili, N. Lagdali, M. Borahma and FZ. Ajana. Risks of Lymphoma and Digestive Cancers in Patients with Celiac Disease: Cohort Study. International Journal of Celiac Disease. 2020; 8(2):50-53. doi: 10.12691/ijcd-8-2-2

Abstract

BACKGROUND: The association between celiac disease (CD) and the development of various malignant tumors, in particular gastrointestinal cancers, has been reported by several studies. However, the close relative risks (Odds Ratio) of these complications compared to the population are still insufficiently known and estimates of the risk factors for the development of these complications in patients followed for CD remain controversial. Objective: To estimate the close relative risks of malignant complications in a cohort of patients with celiac disease compared to the Moroccan population and to determine the risk factors for the development of these complications. Methods: Our work is a retrospective, descriptive and analytical study, carried out within the Department of Medicine C of the CHU IBN SINA Mohammed V University of Rabat, over a period of 23 years - between 1995 and 2018 -, and on a basis of 284 cases of celiac disease, from which we have extracted a series of 16 cases of celiac disease with at least one malignant gastrointestinal complication. Using a case-control study, we were able to determine the risk of these complications compared to the general Moroccan population. Results: We gathered a population of 16 celiac patients with one or more malignant gastrointestinal complications, out of a total of 284 cases of CD, the prevalence was 5.6%. We found a significant increase in the risk of developing digestive malignancies during CD with an Odds Ratio (OR) of 46 (95% confidence interval [CI] 34–63) and p value <0.0001). This risk was higher during the period of per diagnosis, we also objectified a significant increase in risk of all types of cancers found in our series compared to those of control cases. The two risk factors for malignant complications found in our study are non-compliance with the gluten-free diet and delayed diagnosis. Conclusions: There is a significant increase in the risk of malignancy in patients diagnosed with CD. Particularly during the period of per diagnosis. This risk according to this cohort can be reduced by the good observance of the gluten-free diet and an early diagnosis in the face of the most severe symptoms of this pathology.

Keywords:
celiac disease lymphoma digestive cancer

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Meresse B, Malamut G, Cerf-Bensussan N. Celiac disease: A immunological jigsaw. Immunity 2012; 36: 907-19.
 
[2]  Ludvigsson JF, PH vert. Prise en charge clinique de la maladie cœliaque. J Intern Med 2011; 269: 560-571.
 
[3]  Kupper C. Directives alimentaires et mise en œuvre de la maladie cœliaque. Gastroenterology 2005; 128 (4 suppl 1): S121-S127.
 
[4]  Yuehua Han, MD, Wuzhen Chen, MD, Peiwei Li, MD, and Jun Ye, MD Association Between Coeliac Disease and Risk of Any Malignancy and Gastrointestinal Malignancy A Meta-Analysis Medicine Volume 94, Number 38, September 2015.
 
[5]  West J, Logan RF, juge en chef Smith, et al. Tumeur maligne et mortalité chez les personnes atteintes de la maladie cœliaque: étude de cohorte basée sur la population . BMJ 2004; 329: 716-719.
 
[6]  Virta LJ, Kaukinen K, Collin P. Incidence et prévalence de la maladie cœliaque diagnostiquée en Finlande: résultats d'une détection efficace des cas chez l'adulte . Scand J Gastroenterol 2009; 44: 933-938.
 
[7]  Tom van Gils1, Petula Nijeboer, Lucy IH Overbeek, Michael Hauptmann, Daan AR Castelijn, Gerd Bouma, Chris JJ Mulder, Flora E van Leeuwen and Daphne de Jong Risks for lymphoma and gastrointestinal carcinoma in patients with newly diagnosed adult-onset celiac disease: Consequences for follow-up Celiac disease, lymphoma and GI carcinoma United European Gastroenterology Journal 0(0) 1-11. 2018.
 
[8]  Holmes GK, Prior P, Lane MR, et al. Tumeur maligne dans la maladie cœliaque - effet d'un régime sans gluten . Gut 1989; 30: 333-338.
 
[9]  W. Eigner, K. Bashir, C. Primas, L. Kazemi-Shirazi, F. Wrba†, M. Trauner & H. Vogelsang Dynamics of occurrence of refractory coeliac disease and associated complications over 25 years Aliment Pharmacol Ther 2017; 45: 364-372 2016 John Wiley & Sons Ltd.